Alessia Lamolinara

1.8k total citations
38 papers, 889 citations indexed

About

Alessia Lamolinara is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alessia Lamolinara has authored 38 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alessia Lamolinara's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Neuroblastoma Research and Treatments (5 papers). Alessia Lamolinara is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Neuroblastoma Research and Treatments (5 papers). Alessia Lamolinara collaborates with scholars based in Italy, United States and United Kingdom. Alessia Lamolinara's co-authors include Manuela Iezzi, Antonio Recchiuti, Domenico Mattoscio, Elisa Isopi, Mario Romano, Sara Patruno, Vincenzo De Laurenzi, Patrizia Nanni, Pier‐Luigi Lollini and Arianna Palladini and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Alessia Lamolinara

35 papers receiving 882 citations

Peers

Alessia Lamolinara
Chun Deng China
Norma Llansa United States
LM Pelus United States
Russell Ericksen United States
Alessia Lamolinara
Citations per year, relative to Alessia Lamolinara Alessia Lamolinara (= 1×) peers Katharina Tschoep

Countries citing papers authored by Alessia Lamolinara

Since Specialization
Citations

This map shows the geographic impact of Alessia Lamolinara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Lamolinara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Lamolinara more than expected).

Fields of papers citing papers by Alessia Lamolinara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Lamolinara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Lamolinara. The network helps show where Alessia Lamolinara may publish in the future.

Co-authorship network of co-authors of Alessia Lamolinara

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Lamolinara. A scholar is included among the top collaborators of Alessia Lamolinara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Lamolinara. Alessia Lamolinara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capone, Emily, Alessia Lamolinara, Manuela Iezzi, et al.. (2024). EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate. Journal of Controlled Release. 374. 171–180. 4 indexed citations
2.
Recinella, Lucia, Serena Veschi, Guya Diletta Marconi, et al.. (2023). Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice. Cells. 12(22). 2615–2615. 6 indexed citations
3.
Lamolinara, Alessia, Ilaria Cicalini, Maria Concetta Cufaro, et al.. (2023). Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance. Molecular Metabolism. 74. 101752–101752. 1 indexed citations
4.
Ranelletti, Franco O., Paolo Felaco, Luca Gattinoni, et al.. (2023). Independent Prognostic and Predictive Role of Interstitial Macrophages in Kidney Biopsies of IgA Nephropathy Patients. Journal of Personalized Medicine. 13(6). 935–935.
5.
Macagno, Marco, Elisabetta Bolli, Federica Riccardo, et al.. (2022). Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis. Biomedicines. 10(2). 230–230. 1 indexed citations
6.
Bruno, Annalisa, Annalisa Contursi, Stefania Tacconelli, et al.. (2022). The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in Apc mice. Pharmacological Research. 185. 106506–106506. 14 indexed citations
8.
Lamolinara, Alessia, Emily Capone, Stefania Purgato, et al.. (2020). Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac. Oncogenesis. 9(1). 3–3. 8 indexed citations
9.
Rolih, Valeria, Jerri C. Caldeira, Elisabetta Bolli, et al.. (2020). Development of a VLP-Based Vaccine Displaying an xCT Extracellular Domain for the Treatment of Metastatic Breast Cancer. Cancers. 12(6). 1492–1492. 28 indexed citations
10.
Isopi, Elisa, Domenico Mattoscio, Marilina Codagnone, et al.. (2020). Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis. Frontiers in Immunology. 11. 581–581. 58 indexed citations
11.
Faraci, Simona, Claudia Chiodoni, Egidio Iorio, et al.. (2019). Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment. Cellular Oncology. 42(6). 815–828. 18 indexed citations
12.
Giansanti, Francesco, Emily Capone, Enza Piccolo, et al.. (2018). Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates. Journal of Controlled Release. 294. 176–184. 32 indexed citations
13.
Capone, Emily, Alessia Lamolinara, Daniela D’Agostino, et al.. (2018). EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma. Journal of Controlled Release. 277. 48–56. 28 indexed citations
14.
Mattè, Alessandro, Antonio Recchiuti, Enrica Federti, et al.. (2018). Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1. Blood. 133(3). 252–265. 55 indexed citations
15.
Castiello, Luciano, Paola Sestili, Giovanna Schiavoni, et al.. (2018). Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells. Cancer Immunology Research. 6(6). 658–670. 35 indexed citations
16.
Mastropasqua, Rodolfo, Rossella D’Aloisio, Marta Di Nicola, et al.. (2018). Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema. Scientific Reports. 8(1). 16548–16548. 41 indexed citations
17.
Bobisse, Sara, Alessia Lamolinara, Francesco De Sanctis, et al.. (2016). Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies. Cancer Research. 76(9). 2540–2551. 25 indexed citations
18.
Castagnoli, Lorenzo, Gaia C. Ghedini, Tiziana Triulzi, et al.. (2016). Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer. Oncogene. 36(12). 1721–1732. 31 indexed citations
19.
Lamolinara, Alessia, et al.. (2015). Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor. Journal of Immunology Research. 2015. 1–10. 11 indexed citations
20.
Steven, André, Chiara Massa, Manuela Iezzi, et al.. (2013). HER-2/neu Mediates Oncogenic Transformation via Altered CREB Expression and Function. Molecular Cancer Research. 11(11). 1462–1477. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026